UNC Lineberger News

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery

Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach.

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery - Read More…

36th Annual UNC Lineberger Scientific Symposium

UNC Lineberger’s 36th annual scientific symposium drew large crowds, with over 450 participants.

36th Annual UNC Lineberger Scientific Symposium - Read More…

Armistead receives Mentored Clinical Scientist Development Award

Armistead receives Mentored Clinical Scientist Development Award

Paul Armistead, MD, PhD, has received a grant of more than $396,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study leukemia stem cell-associated minor histocompatibility antigens.

Armistead receives Mentored Clinical Scientist Development Award - Read More…

UNC junior’s research honored at American Association for Cancer Research meeting

UNC junior’s research honored at American Association for Cancer Research meeting

UNC junior Molly DeCristo attended her first international scientific meeting, but not just as a participant. The American Association for Cancer Research (AACR) honored her poster with a rosette, judging it as “highly rated,” among the top 2.5 percent of those submitted.

UNC junior’s research honored at American Association for Cancer Research meeting - Read More…

Joyce Wilson: On Trips of a Lifetime, Planned and Unplanned

A Wayne County woman doesn’t let cancer, its treatment or its recurrence get in the way of her plans to attend her oldest granddaughter’s high school graduation or her own 45th high school reunion.

Joyce Wilson: On Trips of a Lifetime, Planned and Unplanned - Read More…

Intensity Modulated Radiation Therapy optimal for localized prostate cancer

Chapel Hill - A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, according to a study published in the April 18, 2012 issue of the Journal of the American Medical Association. In 2012, approximately 241,740 American men will be diagnosed with prostate cancer.

Intensity Modulated Radiation Therapy optimal for localized prostate cancer - Read More…

International panel recommends new model for breast cancer care

CHAPEL HILL, N.C. - As the number of breast cancer survivors increases, now estimated at 2.8 million, more will be living with the chronic effects of cancer treatments or with advanced disease.

International panel recommends new model for breast cancer care - Read More…

Coghill receives grant to study graft versus host disease

Coghill receives grant to study graft versus host disease

James Coghill, MD, has received a grant of more than $529,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study a promising target for new therapies to combat graft versus host disease, a serious complication of treatment for many blood cancers.

Coghill receives grant to study graft versus host disease - Read More…

UNC scientists describe protein that protects against colon cancer

Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.

UNC scientists describe protein that protects against colon cancer - Read More…